← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Abalone Bio, Inc.
Emeryville, CA
$7,445,421
Total funding
9
Grants
Funding over time
peak $2.4M · FY2018–24$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,620,424 · 7
NSF$1,824,997 · 2
By mechanism
R44$3,978,999 · 2
—$1,824,997 · 2
R43$1,641,425 · 5
Investigators at Abalone Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: A platform for identifying antibodies that modulate human membrane receptors involved in disease$1,599,997
· FY2019 · TIP
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain$1,063,128
R44 · FY2022 · CA
Therapeutic antibodies for treating liver fibrosis$999,999
R44 · FY2023 · DK
Therapeutic antibodies for treating liver fibrosis$999,999
R44 · FY2022 · DK
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain$915,873
R44 · FY2021 · CA
A peripherally restricted MOR agonist for effective pain management with reduced risks$399,230
R43 · FY2024 · DA
Therapeutic antibodies for treating liver fibrosis$349,013
R43 · FY2020 · DK
Therapeutic Antibodies for Treating Inflammatory Bowel Disease$300,241
R43 · FY2021 · DK
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain$299,999
R43 · FY2019 · CA
Antibody agonist for a G protein-coupled receptor as a treatment for pain in endometriosis$292,942
R43 · FY2022 · HD
SBIR Phase I: A platform for identifying antibodies that modulate human membrane receptors involved in disease$225,000
· FY2018 · TIP